Disruptive Healthcare: CEO video series - Peter Keeling, Diaceutics
XX.XX.XX
Diaceutics is a £xxm market cap company that uses proprietary data to provide services to the pharma industry in order to improve access to precision medicines, one the fastest growing markets in healthcare. In this video, CEO Peter Keeling discusses the increasing importance of precision medicine to the pharmaceutical industry, the barriers to its uptake, how COVID-19 is enhancing the importance of Diaceutic’s services and why the launch of its platform DXRX could be a game-changer for the business.
*The views in these video are of CEO of Diaceutics, Peter Keeling
This communication is for use only by a person or entity that qualifies as a "Professional Client" or "Eligible Counterparty" within the meaning of the FCA's rules. It is intended for use only by persons having professional experience in matters relating to investments. Any other person who receives this should not act on the contents. Disclaimer here
